De novo variants detected in patients without an established cause for disease raises the possibility that genes involved in immune/stress response such as APOBEC, TRIB3, or SLC2A6 could be relevant for cardiomyopathy development, especially in patients with disease onset associated with infection/infestation. This evidence concerns the gene SLC2A6 and cardiomyopathy.